Classification Committee

Name	Company
Theresa Ormiston (Managing Chair)	IQVIA - UK
Anthony Palkovic (Co-Chair Intellus)	Merck - USA
Martin Molthagen (Co-Chair EPHMRA)	Lilly - Germany
RK Arora	Novartis - India
Marilena Lauriola	MSD - Italy
Vijay Chand	AstraZeneca - UK
Rainer Deuter	Norgine - Germany
Takayuki Ohhama (Special Liaison Japan)	Lilly - Japan
Layla Chen (Special Liaison China)	Lilly - China
Philip Reynolds	IQVIA - UK
James Street	Specialist Adviser - USA

Developing and improving the Anatomical Classification system in line with changes in pharmaceutical markets
Providing information to ensure the correct classification of products in secondary data supplier services
Responding to requests on classification issues from users of the system
Liaising with the WHO to ensure that the two classification systems converge rather than diverge
Communicating changes to Intellus (minutes, exchange of information, etc.)
Conducting a survey of EphMRA & Intellus on proposed changes to the classification system
Reconciliation of differences of opinions in the classification of products.

NEW! Apprentice Opportunity on Classification Committee (for pharma members) - read on. Please use this Application Form

WHO ATC 2021 Comparison - booklet here

Who we are, What we Do - updated booklet July 2019